IESE (España)
-
PromoFarma 2018
Canals Margalef, Jorge; Masclans, R.Case SM-1692-ECorporate Governance, StrategyThis case explores the strategic challenges experienced in 2018 by the founders of PromoFarma, a software company that sells and distributes health and beauty products. In particular, the case raises: - Some strategic decisions needing to be taken - A process of internationalization - The search for future company shareholders - The design of the company's governanceStarting at €8.20
-
The Clinton Economic Program
Canals, JordiCase ASE-297-EEconomicsThis case sets the ground for a discussion of the main problems of the US economy in the 1990s and the new economic plan designed by President Clinton.Starting at €8.20
-
El programa económico de Clinton
Canals, JordiCase ASE-297EconomicsEste caso prepara el terreno para una discusión de los principales problemas de la economía de Estados Unidos en los años noventa y el nuevo plan económico diseñado por el presidente Clinton.Starting at €8.20
-
La reducción de impuestos del presidente Kennedy
Canals, JordiCase ASE-208EconomicsEl caso permite discutir la efectividad de la política fiscal para estimular la actividad económica. [Es una versión abreviada y modificada del caso The Tax Cut of 1964 (ASE-24)].Starting at €8.20
-
PromoFarma
Canals Margalef, Jorge; Masclans, R.Case SM-1692Corporate Governance, StrategyEste caso plantea los retos estratégicos que los fundadores de PromoFarma, una empresa de software que vende y distribuye productos de parafarmacia, tienen en 2018. En particular, el caso plantea: - Unas decisiones estratégicas a tomar - Un proceso de internacionalización - La búsqueda de los futuros accionistas de la empresa - El diseño del gobierno de la empresaStarting at €8.20
-
Glaxo: The acquisition of Wellcome
Canals, Jordi; Bardolet Urgellès, DavidCase ASE-386-EEconomicsThis case describes the changes in the world pharmaceutical industry in 1995 and presents the challenges for Glaxo (the leading European pharmaceutical firm) and the potential acquisition of Wellcome. This decision will differ from other acquisitions made by firms like Merck, oriented towards vertical integration and control over the distribution network. The main topics that the case covers are: industry analysis; value chain analysis; positioni...Starting at €8.20